Medical treatment is critical to prevent overdose and death. Research shows that with MAT, 75% of patients will still be in recovery one year later. Conversely, studies demonstrate that within one month of stopping buprenorphine treatment, more than 50% of patients relapse to illicit opioid use.
When taken as prescribed by a board-certified specialist, the goal of Suboxone treatment is to ease opioid
When taken as prescribed by a board-certified specialist, the goal of Suboxone treatment is to ease opioid
Why Suboxone?
1.
Suboxone is safe
Buprenorphine/naloxone (Suboxone) is widely considered to be safer than methadone and has a lower risk for sedation and overdose when taken as prescribed.
Buprenorphine/naloxone (Suboxone) is widely considered to be safer than methadone and has a lower risk for sedation and overdose when taken as prescribed.
2.
Suboxone is effective
The recommended effective dose is well-known and can be safely reached within 1-2 days for most patients, whereas effective methadone dosing varies unpredictably from person-to-person and may take weeks to achieve.
3.
Suboxone is easily Available
Buprenorphine/naloxone (Suboxone) can be prescribed by licensed and trained medical providers in any treatment setting, whereas methadone is strictly regulated and can only be provided through federally and state licensed opioid treatment programs. Care at such programs is highly standardized which limits individualization of treatment.
1.
Suboxone is safe
Buprenorphine/naloxone (Suboxone) is widely considered to be safer than methadone and has a lower risk for sedation and overdose when taken as prescribed.
Buprenorphine/naloxone (Suboxone) is widely considered to be safer than methadone and has a lower risk for sedation and overdose when taken as prescribed.
2.
Suboxone is effective
The recommended effective dose is well-known and can be safely reached within 1-2 days for most patients, whereas effective methadone dosing varies unpredictably from person-to-person and may take weeks to achieve.
3.
Suboxone is easily Available
Buprenorphine/naloxone (Suboxone) can be prescribed by licensed and trained medical providers in any treatment setting, whereas methadone is strictly regulated and can only be provided through federally and state licensed opioid treatment programs. Care at such programs is highly standardized which limits individualization of treatment.
Important safety information SUBOXONE is indicated for the treatment of opioid dependence in adults. SUBOXONE should not be taken by individuals who have been shown to be hypersensitive to buprenorphine or naloxone as serious adverse reactions, including anaphylactic shock, have been reported. Taking SUBOXONE with other opioid medicines, benzodiazepines, alcohol, or other central nervous system depressants can cause breathing problems that can lead to coma and death. Other side-effects may include headaches, nausea, vomiting, constipation, insomnia, pain, increased sweating, sleepiness, dizziness, coordination problems, physical dependence or abuse, and liver problems. For more information about SUBOXONE, see Suboxone.com, the full Prescribing Information, and Medication Guide or talk to your healthcare provider. You are encouraged to report negative side effects of drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.